Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial

Santiago Ponce Aix, Tudor–Eliade Ciuleanu, Alejandro Navarro, Sophie Cousin, Laura Bonanno, Egbert F. Smit, Alberto Chiappori, M.E. Olmedo, Ildikó Horváth, Christian Grohé, Anna F. Farago, José Antonio López-Vilariño, Martín Cullell-Young, Antonio Nieto, Noelia Vasco, Javier Gómez, Carmen Kahatt, Ali Zeaiter, Enric Carcereny, Jaromı́r Roubec, Konstantinos Syrigos, Gregory Lo, I. Barneto, Anthony Pope, Amparo Martínez Sánchez, Joseph Kattan, Paul Zarogoulidis, Cornelius F. Waller, Helge Bischoff, Óscar Juan, Niels Reinmuth, Manuel Dómine, Luis Paz‐Ares